Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Jul;80(9):1400–1404. doi: 10.1038/sj.bjc.6690535

The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers

T Björk-Eriksson 1, C M L West 5, E Cvetskovska 2, M Svensson 3, E Karlsson 1, B Magnusson 4, N J Slevin 5, S Edström 2, C Mercke 1
PMCID: PMC2363068  PMID: 10424742

Abstract

A study was made of the relationship between measurements of radiosensitivity versus proliferation and p53 status in head and neck cancers. Inherent tumour radiosensitivity was assessed as surviving fraction at 2 Gy (SF2) using a clonogenic soft agar assay (n = 77). The results were compared to data on proliferation obtained by both flow cytometry (labelling index (LI), the potential doubling time (Tpot) n = 55) and immunohistochemistry (Ki-67 and PCNA; n = 68), together with immunohistochemical p53 expression (n = 68). There were no overall significant differences in the median values of the various parameters analysed for the different sites within the head and neck region, disease stages, grades of tumour differentiation or nodal states. A subgroup analysis showed that oropharyngeal (n = 22) versus oral cavity (n = 35) tumours were more radiosensitive (P = 0.056) and had a higher Ki-67 index (P = 0.001). Node-positive tumours had higher LI (P = 0.021) and a trend towards lower Tpot (P = 0.067) values than node-negative ones. No correlations were seen between SF2 and any of the parameters studied. The long-standing dogma of an increased radiosensitivity of rapidly proliferating cells in contrast to slowly proliferating cells was not confirmed. The study shows that parallel measurements of different biological markers can be obtained for a large number of patients with head and neck cancers. The independence of the various parameters studied suggests that there may be potential for their combined use as prognostic factors for the outcome of radiotherapy. © 1999 Cancer Research Campaign

Keywords: proliferation, p53, radiosensitivity, head and neck cancer

Full Text

The Full Text of this article is available as a PDF (70.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begg A. C. The clinical status of Tpot as a predictor? Or why no tempest in the Tpot! Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1539–1541. doi: 10.1016/0360-3016(95)00261-V. [DOI] [PubMed] [Google Scholar]
  2. Björk-Eriksson T., West C. M., Karlsson E., Slevin N. J., Davidson S. E., James R. D., Mercke C. The in vitro radiosensitivity of human head and neck cancers. Br J Cancer. 1998 Jun;77(12):2371–2375. doi: 10.1038/bjc.1998.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bourhis J., Bosq J., Wilson G. D., Bressac B., Talbot M., Leridant A. M., Dendale R., Janin N., Armand J. P., Luboinski B. Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. Int J Cancer. 1994 May 15;57(4):458–462. doi: 10.1002/ijc.2910570403. [DOI] [PubMed] [Google Scholar]
  4. Bourhis J., Wilson G., Wibault P., Bosq J., Chavaudra N., Janot F., Luboinski B., Eschwege F., Malaise E. P. In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys. 1993 Aug 1;26(5):793–799. doi: 10.1016/0360-3016(93)90494-g. [DOI] [PubMed] [Google Scholar]
  5. Brachman D. G., Beckett M., Graves D., Haraf D., Vokes E., Weichselbaum R. R. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res. 1993 Aug 15;53(16):3667–3669. [PubMed] [Google Scholar]
  6. Bradford C. R., Zhu S., Wolf G. T., Poore J., Fisher S. G., Beals T., McClatchey K. D., Carey T. E. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Otolaryngol Head Neck Surg. 1995 Oct;113(4):408–412. doi: 10.1016/s0194-5998(95)70077-3. [DOI] [PubMed] [Google Scholar]
  7. Bristow R. G., Benchimol S., Hill R. P. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol. 1996 Sep;40(3):197–223. doi: 10.1016/0167-8140(96)01806-3. [DOI] [PubMed] [Google Scholar]
  8. Brock W. A., Baker F. L., Wike J. L., Sivon S. L., Peters L. J. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys. 1990 Jun;18(6):1283–1286. doi: 10.1016/0360-3016(90)90298-x. [DOI] [PubMed] [Google Scholar]
  9. Calzolari A., Chiarelli I., Bianchi S., Messerini L., Gallo O., Porfirio B., Mattiuz P. L. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer. Am J Clin Pathol. 1997 Jan;107(1):7–11. doi: 10.1093/ajcp/107.1.7. [DOI] [PubMed] [Google Scholar]
  10. Eschwege F., Bourhis J., Girinski T., Lartigau E., Guichard M., Deblé D., Kepta L., Wilson G. D., Luboinski B. Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience. Int J Radiat Oncol Biol Phys. 1997 Nov 1;39(4):849–853. doi: 10.1016/s0360-3016(97)00509-9. [DOI] [PubMed] [Google Scholar]
  11. Field J. K., Pavelic Z. P., Spandidos D. A., Stambrook P. J., Jones A. S., Gluckman J. L. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1993 Oct;119(10):1118–1122. doi: 10.1001/archotol.1993.01880220064009. [DOI] [PubMed] [Google Scholar]
  12. Girinsky T., Bernheim A., Lubin R., Tavakoli-Razavi T., Baker F., Janot F., Wibault P., Cosset J. M., Duvillard P., Duverger A. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival. Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):789–794. doi: 10.1016/0360-3016(94)90350-6. [DOI] [PubMed] [Google Scholar]
  13. Levine E. L., Renehan A., Gossiel R., Davidson S. E., Roberts S. A., Chadwick C., Wilks D. P., Potten C. S., Hendry J. H., Hunter R. D. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol. 1995 Oct;37(1):1–9. doi: 10.1016/0167-8140(95)01622-n. [DOI] [PubMed] [Google Scholar]
  14. Lydén E., Cvetkovska E., Westin T., Oldfors A., Soussi B., Gustafsson B., Edström S. Effects of nandrolone propionate on experimental tumor growth and cancer cachexia. Metabolism. 1995 Apr;44(4):445–451. doi: 10.1016/0026-0495(95)90050-0. [DOI] [PubMed] [Google Scholar]
  15. Narayana A., Vaughan A. T., Gunaratne S., Kathuria S., Walter S. A., Reddy S. P. Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer. 1998 Jan 15;82(2):286–291. doi: 10.1002/(sici)1097-0142(19980115)82:2<286::aid-cncr7>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  16. Nylander K., Stenling R., Gustafsson H., Zackrisson B., Roos G. p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer. 1995 Jan 1;75(1):87–93. doi: 10.1002/1097-0142(19950101)75:1<87::aid-cncr2820750115>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  17. Pekkola-Heino K., Joensuu H., Klemi P., Grenman R. Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous carcinoma cell lines. Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):750–754. doi: 10.1001/archotol.1994.01880310054010. [DOI] [PubMed] [Google Scholar]
  18. Pekkola-Heino K., Servomaa K., Kiuru A., Grenman R. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma. Acta Otolaryngol. 1996 Mar;116(2):341–344. doi: 10.3109/00016489609137854. [DOI] [PubMed] [Google Scholar]
  19. Raybaud-Diogène H., Fortin A., Morency R., Roy J., Monteil R. A., Têtu B. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol. 1997 Mar;15(3):1030–1038. doi: 10.1200/JCO.1997.15.3.1030. [DOI] [PubMed] [Google Scholar]
  20. Sauter E. R., Ridge J. A., Gordon J., Eisenberg B. L. p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base. Am J Surg. 1992 Dec;164(6):651–653. doi: 10.1016/s0002-9610(05)80727-5. [DOI] [PubMed] [Google Scholar]
  21. Siles E., Villalobos M., Valenzuela M. T., Núez M. I., Gordon A., McMillan T. J., Pedraza V., Ruiz de Almodóvar J. M. Relationship between p53 status and radiosensitivity in human tumour cell lines. Br J Cancer. 1996 Mar;73(5):581–588. doi: 10.1038/bjc.1996.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tucker S. L., Thames H. D., Jr The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: a theoretical evaluation. Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):145–157. doi: 10.1016/0360-3016(89)90382-9. [DOI] [PubMed] [Google Scholar]
  23. Warenius H. M., Britten R. A., Browning P. G., Morton I. E., Peacock J. H. Identification of human in vitro cell lines with greater intrinsic cellular radiosensitivity to 62.5 MeV (p-->Be+) neutrons than 4 MeV photons. Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):913–920. doi: 10.1016/0360-3016(94)90112-0. [DOI] [PubMed] [Google Scholar]
  24. West C. M., Davidson S. E., Roberts S. A., Hunter R. D. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer. 1997;76(9):1184–1190. doi: 10.1038/bjc.1997.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. West C. M. Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol. 1995 Aug;68(812):827–837. doi: 10.1259/0007-1285-68-812-827. [DOI] [PubMed] [Google Scholar]
  26. Wilson G. D., Richman P. I., Dische S., Saunders M. I., Robinson B., Daley F. M., Ross D. A. p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. Br J Cancer. 1995 Jun;71(6):1248–1252. doi: 10.1038/bjc.1995.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yin Y., Tainsky M. A., Bischoff F. Z., Strong L. C., Wahl G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 1992 Sep 18;70(6):937–948. doi: 10.1016/0092-8674(92)90244-7. [DOI] [PubMed] [Google Scholar]
  28. Zackrisson B., Gustafsson H., Stenling R., Flygare P., Wilson G. D. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):677–683. doi: 10.1016/s0360-3016(97)00066-7. [DOI] [PubMed] [Google Scholar]
  29. Zaffaroni N., Benini E., Gornati D., Bearzatto A., Silvestrini R. Lack of a correlation between p53 protein expression and radiation response in human tumor primary cultures. Stem Cells. 1995 Jan;13(1):77–85. doi: 10.1002/stem.5530130110. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES